Health-Chem Makes Announcement.NEW YORK--(BUSINESS WIRE)--Oct. 1, 1997--Health-Chem Corporation (ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. :HCH) and its 90%-owned Transderm Laboratories Corporation subsidiary (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). :TLCC) today announced that the United States District Court for the District of Delaware The United States District Court for the District of Delaware is the Federal district court having jurisdiction over the entire state of Delaware. The Court sits in Wilmington. Currently, three judges and two magistrate judges preside over the court. yesterday ruled in favor of Key Pharmaceuticals, Inc. ("Key") in its patent litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. against Transderm's Hercon Laboratories Corporation ("Hercon") subsidiary. This civil action was originally filed in August 1995 by Key against Hercon alleging that Hercon's submission to the United States Food and Drug Administration United States Food and Drug Administration (FDA), n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics. of several Abbreviated New Drug Applications relating to some of Hercon's improved transdermal nitroglycerin nitroglycerin (nī'trōglĭs`ərĭn), C3H5N3O9, colorless, oily, highly explosive liquid. It is the nitric acid triester of glycerol and is more correctly called glycerol trinitrate. patches constituted infringement of Key's patent for its Nitro-Dur products. Hercon had counterclaimed that Key's patent was invalid and unenforceable and that Hercon had not infringed any claim of the patent. Health-Chem and Transderm are currently reviewing their options in this matter, including an appeal of this decision, which appeal would be filed within 30 days of the ruling. Health-Chem Corporation is the parent company of Transderm Laboratories Corporation, a manufacturer of controlled release pharmaceuticals, as well as other subsidiaries that manufacture products utilizing technologies for laminating or coating fabrics and materials. CONTACT: Health-Chem Corporation, New York Bruce M. Schloss, 212/398-0700 or INVESTOR RELATIONS FIRM: The Equity Group Inc., New York Tamara Ehlin, 212/836-9607 Robert Goldstein, 212/371-8660 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion